|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/12 | |
| A61K 39/085 | |||
| A61K 39/00 | |||
| A61P 31/04 |
| (11) | Number of the document | 2464665 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10743037.3 |
| Date of filing the European patent application | 2010-08-10 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/004884 |
| Date | 2010-08-10 |
| (87) | Number | WO 2011/018208 |
| Date | 2011-02-17 |
| (30) | Number | Date | Country code |
| 09010311 | 2009-08-10 | EP | |
| 266330 P | 2009-12-03 | US |
| (72) |
RUDOLF, Michael, CH
KOCH, Holger, CH
|
| (73) |
Aridis Pharmaceuticals, Inc.,
5941 Optical Court, San Jose, CA 95138,
US
|
| (54) | HUMAN MONOCLONAL ANTIBODY AGAINST S. AUREUS DERIVED ALPHA-TOXIN AND ITS USE IN TREATING OR PREVENTING ABSCESS FORMATION |
| HUMAN MONOCLONAL ANTIBODY AGAINST S. AUREUS DERIVED ALPHA-TOXIN AND ITS USE IN TREATING OR PREVENTING ABSCESS FORMATION |